Home / Stocks / INDOUS
Back to all stocks
NSE · INDOUS

Indo Us Biotech Limited (INDOUS) Share Price

Sector: Healthcare · ISIN: INE250Z01010

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,765
of 5,047 stocks
▼ 161W▼ 661M
Peak #2,596 · 02 Oct 2026

Operating in Healthcare, Indo Us Biotech Limited trades at an undemanding earnings multiple, remains firmly promoter-controlled, with promoters holding 68%, and is growing revenue modestly. Ownership as of Jun 2026.

Market Cap
132.74 Cr
P/E Ratio
10.12
P/B Ratio
1.43
ROE
14.18%
ROCE
17.27%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ2 2026-27Q1 2026-27Q4 2025-26Q3 2025-26
Revenue15.05 Cr32.99 Cr26.02 Cr22.80 Cr
Net Profit-3.67 Cr3.04 Cr1.97 Cr3.00 Cr
EPS-1.831.510.981.49
Operating Profit-2.83 Cr3.82 Cr2.98 Cr3.93 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
68.29%
Public
31.71%

PUBLIC BREAKDOWN

FII
0.01%
Individuals
24.67%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-DateTypeDetails
03 Dec 2024DividendInterim Dividend - Rs 0.25 Per Share

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs